Additional potential indicators that may be relevant to measure.
| Additional Indicators Suggested at GRAPPA |
|---|
| 1. Shorten time to diagnosis |
| Average time from the first contact with HCP to a rheumatology or dermatology referral |
| Average time from the HCP referral to a dermatology appointment |
| Average time from the HCP referral to a rheumatology appointment |
| 2. Improve multidisciplinary collaboration |
| Percent of PsA staff at the center who participated in at least 1 PsA-related training session in last year |
| Number of educational and collaborative meetings organized between dermatologist, rheumatologist, and other specialists (such as cardiologist, ophthalmologist, etc.) in each quarter |
| Percent attendance at the multidisciplinary networking and community-based meetings every quarter |
| 4. Improve disease monitoring |
| Percent of PsA patients on whom a comprehensive risk/benefit and longterm side effects assessment is conducted in a year (in followup period) |
GRAPPA: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis; HCP: healthcare providers; PsA: psoriatic arthritis.